Download PDFPDF

Are researchers moving away from animal models as a result of poor clinical translation in the field of stroke? An analysis of opinion papers
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    And what about in silico stroke models?

    Dear Pandora and Rebecca,We were quite interested by your paper "Are researchers moving away from animal models as a result of poor clinical translation in the field of stroke? An analysis of opinion papers" (BMJ Open Science, 2020). Thank for this illuminating work which makes concrete what we had in mind since a work published in 2004-2007 (Dronne MA, Boissel JP, Grenier E, Gilquin H, Cucherat M, Hommel M, Barbier E, Bricca G. Mathematical modelling of an ischemic stroke: an integrative approach. Acta Biotheor. 2004;52:255-72; Dronne M.A., Boissel J.P., Grenier E., A mathematical model of ion movements in grey matter during a stroke. J Theor Biol 2006;240:599-615; 247. Dronne MA, Grenier E, Dumont T, Hommel M, Boissel JP. Role of astrocytes in grey matter during stroke: A modelling approach. Brain Res. 2007;1138:231-42; 252. Dronne MA, Grenier E, Chapuisat G, Hommel M, Boissel JP. A modelling approach to explore some hypotheses of the failure of neuroprotective trials in ischemic stroke patients. Prog Biophys Mol Biol. 2008. Grenier E, Dronne MA, Descombes S, Gilquin H, Jaillard A, Hommel M, Boissel JP. A numerical study of the blocking of migraine by Rolando sulcus. Prog Biophys Mol Biol. 2008). At this time there were circa 300 "neuroprotective" agents that had worked on rodent models and failed when tested in stroke patients. We used a mathematical model of acute stroke with a rodent and a human versions. Our simulations showed that drugs reducing...

    Show More
    Conflict of Interest:
    Novadiscovery is developing mathematical models of diseases, including stroke